VEGFA and endophthalmitis: Recent work by Borkar et al. reports safety of bilateral same-day intravitreal anti-VEGF treatment, supporting the observations of our study.23 A recent study conducted in Spain reported no incidence of endophthalmitis occurring in 1,612 injections administered bilaterally.7 Other studies have also reported a similar rate in simultaneous bilateral injections (Table-III).